Home Monitoring in California

Monobind Inc. is a leading independent in vitro diagnostics (IVD) manufacturer founded in 1978 and headquartered in Lake Forest, California. The company develops and manufactures over 160 immunoassay products across its AccuBind® ELISA and AccuLite® CLIA platforms, serving clinical laboratories, point-of-care facilities, and direct-to-patient applications globally. Monobind's portfolio spans multiple assay formats—microplate, monotest, magnetic-bead, lateral flow assays (LFA), and microarray technologies—enabling testing of serum, plasma, and whole blood samples. The company supports scalable workflows from manual reader-based systems to fully automated random-access analyzers. Beyond finished assays, Monobind supplies high-quality biomaterials and specialty reagents including buffers and stabilizers for the global diagnostics industry. Operating under FDA registration and ISO 13485 certification, the company distributes CE-marked products to laboratories and partners in over 100 countries worldwide.

Phase Scientific International Limited develops proprietary diagnostic technology and rapid testing solutions for early disease detection, with focus on cancer and infectious diseases. The company's core innovation is PHASIFY™, a molecular detection platform that enables faster, easier identification of target biomarkers compared to conventional diagnostics. PHASIFY™ powers three product and service lines: INDICAID® at-home rapid tests for point-of-care use; INDICAID lab™ at-home laboratory testing kits; and PHASE lab, a clinical laboratory service offering cancer and infectious disease testing. Recent product launches include FebriDx®, a respiratory pathogen test awarded FDA CLIA waiver (March 2026), and urine-based HPV screening for cervical cancer detection. The company markets solutions for cancer screening, cervical health monitoring, and respiratory/infectious disease diagnostics. Manufacturing and regulatory capabilities include FDA CLIA certification and active clinical research partnerships. The company has raised $34 million Series A funding and maintains operations in Asia and North America, positioning itself as an innovator in preventive diagnostics and non-invasive biomarker detection.

Belun Technology designs and manufactures medical-grade wearable devices and AI-powered software platforms for sleep health monitoring, home sleep apnea testing, and remote patient vital signs monitoring. The company's core offerings include the Belun® Ring, an FDA 510(k)-cleared wearable device that performs home sleep apnea screening and monitors sleep health using clinically validated algorithms, and the Belun® remoVital system, a real-time remote vital signs monitoring solution comprising the Belun® Ring, Belun® COR (body temperature sensor), and a communication hub. The remoVital system measures blood oxygen saturation, pulse rate, and body temperature, with alert functionality designed to enable early detection of clinical deterioration and support timely medical intervention. Products target both consumers seeking self-managed wellness monitoring and healthcare professionals requiring scalable remote monitoring solutions for clinical accuracy and care quality improvement. The company emphasizes medical-grade accuracy, ease of use, and affordability. Belun holds FDA 510(k) clearance for its sleep monitoring and vital signs monitoring systems. The platform employs proprietary AI algorithms for predictive analytics and personalized care delivery. Markets served include home-based sleep apnea screening, remote patient monitoring in residential care facilities, and integrated telehealth/remote care workflows. The company has received strategic investment from IHH Healthcare and Gravity Capital Partners, indicating growth in global expansion and product development.

CloudCath is a digital health medical device company that develops remote monitoring solutions for peritoneal dialysis (PD) patients. The company's flagship product, CloudCath Connect™ PD, is an add-on device for PD cyclers that utilizes optical analysis, IoT sensors, machine learning, and cloud computing to measure turbidity in dialysate effluent. By quantifying fluid analysis rather than relying on subjective visual assessment, CloudCath enables early detection of peritonitis and other complications—on average 3.1 days before patient-reported symptoms. Clinical evidence demonstrates a 45% reduction in peritonitis-related hospitalization and 56% reduction in catheter loss. The system seamlessly integrates with major PD cyclers (Baxter and Fresenius), provides real-time notifications to patients and clinicians, and supports continuous home-based monitoring to shift care from in-center facilities. This innovative approach enhances patient outcomes, improves therapy adherence, and reduces the need for emergency interventions in end-stage renal disease management.

BioIntelliSense develops continuous patient monitoring systems for in-facility and home care settings. The company's flagship product, the BioButton wearable device, captures multiparameter vital signs and biometric data in real time, enabling proactive detection of patient deterioration. The system integrates flexible connectivity options (BioMobile app, BioHub Cellular gateway, BioHub Wi-Fi gateway) with BioDashboard clinical intelligence software for exception-based monitoring and analysis. Clinical studies demonstrate that continuous monitoring reduces unplanned ICU admissions, rapid response team activations, and average length of hospital stay. The platform supports operational efficiency initiatives including length-of-stay reduction, virtual rounding optimization, and telemetry overuse reduction. BioIntelliSense targets hospitals, health systems, skilled nursing facilities, assisted living, home health agencies, and remote patient monitoring providers. The company emphasizes evidence-based outcomes from peer-reviewed publications, including research in the Journal of Clinical Medicine and British Journal of Anaesthesia. Products are designed for both acute care floor monitoring and post-acute care transitions, with reimbursement support for remote patient monitoring (RPM) programs. The system is described as medical-grade and designed for healthcare provider organizations only, not direct consumer purchase.

Handexer LLC manufactures FDA-registered digital hand dynamometers and grip-strengthening devices for consumer, fitness, clinical, and rehabilitation markets. The company's core product is a digital hand-held dynamometer that measures grip strength in pounds and kilograms with high accuracy and easy-reading LCD display. Handexer markets grip strength measurement tools for athletic performance tracking, post-stroke hand function recovery, clinical assessment, and general hand health monitoring. Products include the 265 lb (120 kg) digital hand dynamometer, hand strengthener grip rings (5-piece sets), and carrying cases. The devices are positioned for use in gyms, home recovery programs, physical therapy clinics, and performance training. Handexer holds FDA registration and CE certification; the digital dynamometer won a 2023 Red Dot design award and received an honorable mention award. The company operates a direct-to-consumer e-commerce model with 3,500+ verified customers and maintains educational content on grip strength, hand recovery after stroke, and tennis elbow rehabilitation. Manufacturing and service details are not explicitly disclosed on the website.

Playhouse MD is a Los Angeles-based pediatric medical device company founded in 2023 that designs doctor-developed, playful healthcare products for children and families. The company specializes in reimagining essential home-care medical devices by incorporating engaging character designs, light-up features, and accompanying storytelling guides (Playful Prompts) to reduce healthcare anxiety in children. Core product lines include medicine dispensers, nasal aspirators, infrared thermometers, and nail clippers—all designed with pediatric usability and emotional comfort in mind. Founded by Dr. Kaitlin Wiseman, Sydney Wiseman, and Michael Kamins, Playhouse MD emphasizes transforming routine sick-day care moments into engaging, less intimidating experiences through the Playful Pediatrics™ philosophy.

ACI Medical, LLC is a biomedical engineering firm specializing in non-invasive vascular diagnostic and therapeutic devices for patients with limb- and life-threatening vascular conditions. With over 30 years of experience, the company develops, manufactures, and distributes patented medical devices including the ArtAssist® Arterial Assist Device for peripheral arterial disease, diabetic foot ulcers, and critical limb ischemia; diagnostic tools such as the APG® Air Plethysmograph for venous disease assessment; and compression and augmentation devices like VenaPulse® and UnnaSleeve™. The company operates an FDA-registered contract manufacturing division producing miniature diaphragm pumps for medical and industrial applications, as well as custom plastic injection molding services. ACI Medical devices are available for home use and clinical settings, with strong relationships with VA hospitals nationwide.

True Diagnostics is a medical diagnostics developer and manufacturer specializing in innovative point-of-care and over-the-counter testing solutions. The company designs and produces diagnostic tests and devices to assist physicians in preventing, diagnosing, and treating various medical conditions. True Diagnostics' core offering is the proprietary TrueDX Cassette Technology, a patented diagnostic platform featuring internal calibration methods for flexible assay development. The TrueDX system includes a sample-handling module, integrated reaction pad with immobilized calibrators and reagents, and QR code functionality for automatic assay type detection and patient identification tracking. The cassette platform is engineered for superior shelf-life stability, simple test procedures, and reliable, cost-effective performance across over-the-counter and point-of-care markets. True Diagnostics manufactures disposable over-the-counter readers featuring LCD displays, internal calibration controls, and customizable assay detection. Their products are distributed commercially through major U.S. retailers including Walgreens and Rite Aid. The company operates as a one-stop assay developer and technology partner for organizations seeking point-of-care diagnostic solutions. True Diagnostics serves self-testing, point-of-care testing, and companion diagnostics markets, positioning itself as a provider of lab-quality results in remote and challenging testing environments.

Aptitude Medical Systems is a deep-tech healthcare company specializing in advanced molecular diagnostic testing platforms that deliver lab-quality results without requiring specialized laboratory infrastructure. Founded in 2011 and based in Goleta, California, the company's flagship Metrix platform enables rapid, accurate infectious disease diagnostics in multiple settings including urgent care centers, physician offices, hospitals, pharmacies, and homes. The FDA-authorized Metrix COVID-19 test provides rapid detection of COVID-19 and flu viruses using saliva or swab samples. The company is expanding its molecular testing portfolio to cover respiratory health, sexual health, and other infectious disease conditions. Aptitude's mission centers on democratizing diagnostics by making molecular-level testing accessible, affordable, and operationally simple for healthcare providers and patients globally, while addressing cost and usability challenges inherent in traditional laboratory-based diagnostics.

NeilMed is a leading manufacturer of drug-free, all-natural nasal irrigation and nasal care products. The company specializes in medically-proven devices and solutions for sinus health, allergy relief, and nasal moisture management. Product lines include neti pots (NasaFlo Eco), pulsating nasal wash systems (Sinus Rinse bottles), nasal saline sprays, nasal decongestants, nasal moisturizers, and nasal aspirators (NasaBulb). NeilMed also offers complementary product categories including aromatherapy solutions, baby and pediatric nasal care, ear care, first aid, and accessory devices. The company serves consumers through major nationwide retail channels including Costco, Walmart, Walgreens, CVS, Target, and Kroger, positioning its products as accessible over-the-counter wellness solutions. Products are designed for self-care and home management of sinus and nasal conditions. The company emphasizes safety, simplicity, affordability, and clinical efficacy, with physician testimonials and educational resources supporting product use. NeilMed maintains a customer support infrastructure including instructional videos, FAQ resources, an online "Ask a Doctor" portal, and medical literature library. The company's commitment to accessibility includes comprehensive disability support on its website (WCAG 2.1 AA compliance).

QT Medical, Inc. is a medical device manufacturer specializing in portable, wireless, cloud-connected 12-lead ECG systems for hospital-grade cardiac diagnostics and monitoring. Founded in 2013 and based in Diamond Bar, California, the company provides FDA-cleared solutions for both home-use self-monitoring and professional acute care settings. The QT ECG / PCA 500™ platform features pre-positioned sensors (QHeart®), AI-driven computer interpretation, and HIPAA-compliant cloud storage (ECGcloud®). Products are designed for patients from newborns to adults, reducing lead placement time by up to 70% and minimizing common errors such as limb-lead reversal. The company offers integrated mobile applications (iOS, Android, Windows) and cloud-based workflow management. QT Medical also provides Xpress ECG home delivery services and telemedicine-compatible solutions to enable accessible cardiac care across clinical and home environments.

Element Science, Inc. is a San Francisco-based medical device startup founded in 2013, specializing in clinical-grade wearable solutions for cardiac care. The company's flagship product is the Jewel® Patch Wearable Cardioverter Defibrillator, an adhesive-based patch device designed to treat patients at temporary elevated risk of lethal heart rhythms and sudden cardiac arrest. Unlike traditional bulky defibrillator vests, Jewel® offers a sleek, comfortable, and discreet design that provides 24/7 cardiac monitoring and protection during critical transitions from hospital to home. The device leverages machine learning and data science algorithms to detect and treat dangerous arrhythmias. Element Science has received FDA approval, CE Mark, and UKCA Mark certifications for Jewel®, positioning it as the first and most innovative patch-based wearable cardioverter defibrillator on the market. The company is actively developing a broader pipeline of heart disease solutions that combine wearable technology with predictive analytics to improve patient outcomes and prevent sudden cardiac death.

Cognita Labs is a medical device innovator founded by Rice University researchers, focused on simplifying pulmonary diagnosis and management. The company develops an integrated ecosystem of FDA-cleared, mobile-first devices and cloud platforms for respiratory care that bridge clinical and home settings. Products include PulmoScan (portable airway impedance testing), CapMedic (intelligent inhaler attachment with home spirometry), and UltraSpiro (coaching spirometer). Solutions enable remote patient monitoring, real-time inhaler technique feedback, and data-driven clinical decision-making. Designed for high-volume clinics, pediatric practices, and underserved populations where access to traditional pulmonary function testing is limited.

Vielight Inc manufactures photobiomodulation (PBM) devices for consumer and clinical use, specializing in transcranial and intranasal light therapy systems targeting brain health and systemic wellness. The company's core technology uses safe, non-ionizing red and near-infrared light energy to stimulate mitochondrial ATP production, with applications in cognitive enhancement, neurological conditions, and immune support. Product lines include the Neuro series (Pro 2, Duo, Gamma, Alpha variants) for brain photobiomodulation targeting Alzheimer's disease, traumatic brain injury, Parkinson's disease, mild cognitive impairment, autism, and PTSD; the Vagus device for non-invasive vagal nerve stimulation; the MIP for systemic wellness and immunity; and the X-Plus for thymus stimulation. Vielight has published 30+ peer-reviewed studies in collaboration with leading institutions including UCSF, Harvard, University of Toronto, Boston University, and University of Utah, with 20+ ongoing clinical trials and 800+ research participants. The company holds Health Canada medical device approval and conducts FDA-regulated clinical studies. Devices are marketed directly to consumers, practitioners, athletes, and military/veteran populations. Manufacturing and logistics are based in Hayward, California; administration in Toronto, Ontario; and a USA sales office in Shepherdstown, West Virginia. Over 100,000 devices sold globally with a 4.8/5 customer rating.

NimbleHeart, Inc. manufactures and markets the Physiotrace Smart, a patented dry electrode-based, reusable exercise ECG monitoring system cleared by the FDA (510(k)). The device is designed for early detection and prevention of sudden cardiac events through accessible, user-friendly monitoring outside traditional hospital settings. The system features a non-adhesive harness design with dry electrodes, eliminating the skin irritation and discomfort associated with traditional wet electrode systems. The company offers remote cardiac screening and preventive cardiac risk assessment services, positioning the platform for both clinical use and personal health monitoring. The Physiotrace Smart is engineered for ease of assembly, cleaning, and repackaging, with emphasis on patient comfort during extended wear and exercise testing. NimbleHeart targets individuals at cardiac risk, post-COVID patients with cardiac symptoms, and healthcare providers seeking portable, hygienic alternatives to conventional Holter monitors and exercise stress testing equipment. The company provides thorough clinical reporting and customer support services alongside device provision.

Nonagon Ltd. designs and distributes FDA-cleared telehealth device kits that enable patients to conduct multiple clinical physical exams remotely via smartphone. The Nonagon Care Kit is a portable, all-in-one diagnostic tool that includes a digital thermometer, stethoscope, pulse oximeter, and otoscope (video ear examination). Patients capture vital signs and visual findings, then securely transmit results to US-certified clinicians for virtual consultation. The platform supports up to nine distinct medical exam types, including temperature, skin photography, oxygen saturation, lung auscultation, cardiac auscultation, otoscopy, abdominal sounds, and throat visualization. Clinical applications span acute care (infections, fever, respiratory conditions including COVID-19, COPD, asthma, pneumonia), dermatology (rashes, cuts, bruises), and ENT (ear infections, sore throat, tonsillitis). Nonagon operates a subscription-based model: ConnectCare membership at $7.99/month provides ongoing result-sharing and clinical access; virtual care visits are priced at $39 (adult) and $49 (pediatric, ages 3–17). The Care Kit retails at $239.99 or $19.99 monthly. Device is FDA-cleared; regulatory clearance substantiates clinical accuracy claims. Target markets include direct-to-consumer telemedicine, family health monitoring, concierge practices, and direct-care clinics seeking to close diagnostic gaps in remote settings.

Totex Manufacturing Inc. is a US-based designer and manufacturer of custom battery packs and charging systems serving medical, industrial, aerospace, and consumer markets since 1985 (35+ years of experience). The company provides comprehensive solutions from initial design through manufacturing, testing, and global logistics. In the medical sector, Totex supplies rechargeable batteries and chargers for portable diagnostic devices (ultrasound machines, blood pressure monitors, insulin pumps, portable monitors), portable medical equipment, and ICU/emergency devices requiring reliable power in demanding environments. The company manufactures to rigorous medical standards and maintains FDA registration. Core manufacturing capabilities include circuit design and PCB layout, fuel gauge and MCU firmware programming, in-house SMT assembly (7 fully automatic lines), plastic injection molding (27 machines), ultrasonic and spot welding, and automated cell sorting. Quality systems include ISO 9001, ISO 13485, and ISO 14001 certifications, with in-house UL2054 testing, Six Sigma training (1 master black belt, 2 black belts, 30+ green belts), and DPPMs typically <500 per year. Environmental testing capabilities in-house include temperature cycling, thermal shock, humidity, IP68 dust/water intrusion, vibration, drop, shock, and nail penetration testing. The company operates two manufacturing facilities (Torrance, California: 55,000 sq. ft.; Huizhou, China: 120,000 sq. ft.) with vertical integration enabling cost-effective and consistent production. Expertise spans all major cell chemistries: Li-Ion, LiFePO4, NiMH, Li-SOCl2. Logistics support includes ~98% on-time delivery, Kanban/VMI/consignment programs, and specialized handling of lithium-ion battery shipping regulations. Designs include autoclave and intrinsically safe ratings for medical applications.

HI MEDICAL CO., LTD is a South Korea-based distributor and wholesaler of medical consumables and diagnostic supplies, established in 2009. The company operates as a B2B supplier of branded medical products including blood collection systems, personal care supplies, wound dressings, and home diabetes monitoring equipment. Product portfolio includes BD Vacutainer blood collection tubes, 3M medical consumables (N95 masks, wound dressings, dental materials), ConvaTec ostomy and wound care products, and glucose test strips from major manufacturers including Accu-Chek, OneTouch, and Contour TS. The company also distributes specialty items such as artificial tears (QUTIS), dental filling materials (GANAFILL), and 3M dental impression materials (ESPE EXPRESS). Operating as a distributor and wholesaler with 1–50 employees, HI MEDICAL serves healthcare facilities and potentially retail channels. The company emphasizes customer relationships, credibility, and service quality. No specific FDA 510(k), ISO 13485, or CE marking information is disclosed on the website; products are predominantly from established OEM manufacturers with their own regulatory credentials.

Woddle Baby Inc. manufactures the Woddle Smart Changing Pad, an FDA-registered Class I medical device that integrates multiple infant care functions into a single smart platform. The device combines a changing pad with built-in scale for weight tracking, adjustable night light, heating pad, sound machine, and touchscreen interface. It syncs with the Woddle Baby mobile app to log feeding, diaper changes, sleep, and weight data in real time, providing parents with continuous monitoring and growth tracking between clinical checkups. The system is designed to support early childhood health monitoring and parental confidence during the critical first months of infancy.

Teal Health, Inc. develops and operates the Teal Wand™, an FDA-authorized self-collection device for at-home cervical cancer screening. The company provides a telehealth-integrated cervical cancer screening service that enables women aged 25–65 to collect HPV samples privately at home using the Teal Wand, which are then analyzed using the same Primary HPV test (cobas® HPV from Roche) recommended by the American Cancer Society and U.S. Preventive Services Task Force. Clinical validation demonstrates detection of cervical precancer at 96% sensitivity, equivalent to clinician-collected samples. The service includes virtual consultations with licensed medical providers for screening history review, result interpretation, and coordination of follow-up care when abnormal results warrant referral. Teal Health operates a direct-to-consumer model with insurance integration (Cigna, Aetna, Anthem Blue Cross, Blue Cross Blue Shield, United Healthcare) and HSA/FSA eligibility. Pricing is $99 with insurance or $249 self-pay (reduced from $499). The company emphasizes accessibility and patient comfort, reporting that 94% of clinical trial participants preferred at-home screening over traditional in-office procedures. Teal Health has received recognition including TIME's Best Inventions of 2025 and endorsement from the U.S. Health Department for cervical cancer prevention through at-home screening alternatives.

VitalConnect, Inc. is a remote patient monitoring company specializing in wearable cardiac monitoring devices and integrated telehealth software. The company manufactures the VitalPatch®, an adhesive wearable sensor that continuously monitors electrocardiography (ECG) and multiple vital signs (up to 11 parameters) for patients in hospital and home settings. The VitalPatch RTM (Remote Telemetry Monitoring) is a first-of-its-kind extended Holter monitor technology enabling real-time cardiac data streaming. VitalConnect's integrated software solution combines live ECG monitoring with telehealth-enabled platforms for synchronized clinical review and decision support. Primary markets include remote patient monitoring, hospital-at-home programs, post-discharge cardiac surveillance, and COVID-19 patient monitoring to minimize caregiver exposure while maintaining continuous clinical oversight. The company has demonstrated significant adoption acceleration since 2020, driven by telehealth expansion and remote monitoring adoption in acute care settings. VitalConnect products support both in-hospital and at-home monitoring workflows. The TELESTAR-TAVR clinical study demonstrates clinical validation efforts for transcatheter aortic valve replacement monitoring. The company targets hospital systems, cardiology practices, and home health providers requiring continuous, accessible cardiac monitoring without traditional Holter monitor limitations.

Cala Health is a bioelectronic medicine company specializing in wearable neuromodulation therapies for chronic diseases. Founded in 2014 as a Stanford University spinout, Cala develops non-invasive peripheral nerve stimulation devices using transcutaneous afferent patterned stimulation (TAPS). The company's flagship product, the Cala kIQ, is an FDA-cleared wrist-worn device for reducing action hand tremor in essential tremor and Parkinson's disease patients. The Cala kIQ delivers on-demand TAPS therapy with clinically proven efficacy—patients report tremor reduction within 40 minutes, with relief lasting over 90 minutes post-session. The company supports a comprehensive patient lifecycle ecosystem including prescription fulfillment, insurance reimbursement assistance, connected care services via MyCala.com patient portal, telemedicine consultation, and medication management support. Medicare and VA coverage are available for qualifying beneficiaries. Cala Health is expanding its therapeutic focus to neurology, cardiology, and psychiatry applications.

Baby Health Care, Inc. manufactures and distributes BabySmile brand infant health monitoring and respiratory care devices for direct-to-consumer and retail markets. The company produces two primary product categories: motion sensors for SIDS (Sudden Infant Death Syndrome) monitoring and electric nasal aspirators for pediatric nasal congestion relief. The Baby Motion Sensor (E-202) is a wearable device that monitors infant sleep movement and breathing, alerting parents to potential cessation of movement. The BabySmile Electric Nasal Aspirator line includes the full-size S-504 model with hospital-grade suction power for clearing nasal mucus, and the portable S-303 for on-the-go use. Products are designed under medical supervision and carry endorsements from pediatricians and pediatric specialists including board-certified physicians in allergy and immunology. The company emphasizes ease of use, safety (soft silicone tips), hygiene (removable and washable components), and clinical efficacy in preventing secondary infections such as otitis media and supporting infant sleep quality. Products are sold direct via the company website, Amazon, and third-party retailers. The company claims trusted adoption by over one million parents.

IEI Integration Corp. is a Taiwan-based edge computing and embedded systems manufacturer specializing in AI-ready industrial computers, fanless systems, and medical-grade solutions. The company designs and manufactures box PCs, panel PCs, embedded systems, network appliances, and specialized medical imaging capture systems. IEI offers an ODM (Original Design Manufacturing) service for custom embedded computing solutions across multiple verticals including healthcare, smart factories, autonomous mobile robots, and networking infrastructure. The company holds TFDA (Taiwan FDA) and ISO 13485 certifications for medical device manufacturing, demonstrating compliance with international medical device quality standards. Product lines include the HTB series (medical AI box PCs with 24-core processors and touchscreen displays), TANK AIoT developer kits, PUZZLE network appliances, and the EndoCap-3588 endoscopic image capture and recording system designed for medical visualization and diagnostics. IEI supports Intel and AMD processors, GPU acceleration (Nvidia Quadro RTX), real-time computing with Intel TCC/TSN, and integrated AI inference via OpenVINO and Intel Movidius Myriad X accelerators. The company manufactures in Taiwan with new facility expansion in Yangmei and maintains a US presence through IEI Technology USA Corp. Services include technical support, warranty coverage, software services, and end-of-life product management. IEI serves OEMs, medical device manufacturers, industrial automation integrators, and healthcare facilities requiring edge AI computing, real-time data processing, and ruggedized embedded platforms.

ABENA INTERNATIONAL A/S is a global provider of absorbent hygiene products and healthcare consumables founded in 1953 and headquartered in Denmark. The company manufactures and distributes incontinence products, baby diapers, feminine hygiene products, and related healthcare consumables through in-house production facilities in Europe and a global sourcing network. Key product lines include Abri-Flex (incontinence), ABENA Pants (adult incontinence), Bambo Nature (eco-labeled diapers), and face masks. The company also produces medical textiles and underpad materials through subsidiary ABENA-Frantex. Recent expansion includes acquisition of majority stake in Aquatime, an intelligent drinking glass for monitoring fluid intake to prevent dehydration in elderly care settings. ABENA operates 13+ subsidiaries and distributors across Europe, North America, and globally. The company holds OEKO-TEX® certification, Nordic Swan Ecolabel, ISCC PLUS sustainability certification, and is committed to science-based climate targets (SBTi approval). Manufacturing emphasizes energy efficiency, automation, and quality control with particle analysis capabilities. Markets served include healthcare institutions, nursing homes, industrial food service, and retail. Strong focus on sustainability, responsible sourcing, and employee development across all operations.

Skyward Medical Devices LLC is a direct-to-consumer and B2B distributor of home medical equipment, mobility aids, and wellness products. The company specializes in hospital beds for home use, including hi-low beds, rotating adjustable beds for elderly care, and pediatric safety beds for special needs. Product lines include electric and manual wheelchairs, lift chairs, patient transfer chairs, enclosed mobility scooters, bath and shower lifts, hospital bed mattresses (including air mattresses for pressure relief), and therapeutic devices such as red light therapy systems and infrared mats. Skyward Medical serves homecare patients, elderly individuals, pediatric special needs populations, and rehabilitation facilities. The company emphasizes affordability and quality, sourcing products from established manufacturers. While specific regulatory certifications (FDA 510(k), ISO 13485) are not mentioned in available content, the product categories align with standard medical device and homecare equipment classifications. The company operates primarily as an e-commerce retailer with direct customer sales, offering a curated selection of wellness and mobility solutions designed for home and personal use.

Zepp Health is a consumer health technology company delivering smart wearable healthcare solutions and digital health management platforms. The company manufactures intelligent wearables including smartwatches, smart bands, and smart hearing devices capable of continuous 24/7 health monitoring and biometric data collection. The Zepp Digital Health Management Platform integrates proprietary Zepp OS, AI chips, biometric sensors, and data algorithms to provide cloud-based actionable health insights and personalized wellness guidance. Key capabilities include real-time physiological monitoring, AI-driven sports and sleep coaching, atrial fibrillation detection (with 135,000+ suspected AFib events detected), and generative AI solutions utilizing Large Language Models for natural language interaction. The platform delivers preventative care insights and enables users to understand their health data for informed decision-making. Zepp Health serves a global consumer market with 42+ million active users across 90+ countries and has shipped over 200 million units worldwide. The company collaborates with 25+ world-class research partners and combines audiologist expertise with wearable technology for hearing solutions. Products feature proprietary sensors and algorithms optimized for continuous health tracking, fitness monitoring, sleep analysis, and wellness optimization across consumer segments.

Magnes AG is an ETH Zurich spinoff headquartered in Zurich, Switzerland, specializing in AI-powered gait analysis and mobility support through wearable smart footwear integrated with vibrotactile feedback technology. The company develops sensorized shoes that continuously monitor walking patterns, balance, and gait disruptions in real-world environments, delivering clinical-grade movement data outside traditional laboratory settings. Their core technology uses real-time haptic cues delivered through built-in vibration systems to help users—particularly those with neurological conditions affecting movement—reconnect with their feet and develop more confident walking patterns. Magnes offers three product tiers: NUSHU (medical-grade for healthcare professionals), NUSHU X (consumer wellness), and NUSHU Research (for academic institutions). The NUSHU system captures over 35 gait parameters and employs closed-loop AI algorithms that adapt vibration rhythms, intensities, and patterns to individual patient needs. Applications include support for Parkinson's disease, freezing of gait, mobility disorders, and general activity monitoring. The company has demonstrated clinical partnerships with leading institutions including UC San Diego, Harvard University, Stanford, University of Zurich, and Northumbria University. Since product launch in 2021, Magnes has analyzed millions of steps and maintains multiple ongoing clinical trials. The technology is designed for ease of use—shoes function as standard footwear with no wires or complicated setup—and operates continuously in daily living environments.

OrthoRPM Inc. manufactures Dexterity, a smart connected hand therapy device for remote patient monitoring and rehabilitation. The system provides individual digit assessment and therapy for fingers and grip strength, enabling patients to perform therapy at home while licensed therapists and physicians monitor progress in real-time through a connected portal. The platform includes a patient-facing mobile application for exercise tracking and data submission, and a therapist/physician portal for patient management, result visualization, and clinical oversight. OrthoRPM targets hand therapy specialists, occupational therapists, physical therapists, orthopedic surgeons, and hand surgery practices seeking to deliver remote therapeutic monitoring and improve patient compliance and functional outcomes. The company focuses on converting traditional, in-clinic hand grip assessment and therapy into digitally connected, home-based care. Regulatory status, specific FDA clearances, and manufacturing certifications are not disclosed on the site.

ByFlo Products Inc. is a Montreal-based manufacturer and direct-to-consumer retailer of Health Canada-approved personal medical monitoring devices. The company specializes in digital thermometers and blood pressure monitors designed for home and family use. Product portfolio includes multiple thermometer variants: non-contact infrared forehead thermometers (models PG-IRT1602, JZK-601, JPD-FR301, JPD-FR403), digital oral/rectal/underarm thermometers with flexible tips (DMT-4132, DMT-4333 in blue and pink), and digital blood pressure monitors (FC-BP121). All products are clinically proven and Health Canada-approved. Devices feature user-friendly interfaces, fever alarm functionality, temperature memory storage (up to 20 readings), automatic shut-off, and dual °C/°F display options. Thermometers are marketed for all ages from infants to adults, with specific modes for different measurement types (forehead, ear, object, child modes). The company operates a B2C e-commerce platform with wholesale/B2B inquiry options. Manufacturing and regulatory headquarters are in Montreal, Quebec, Canada. Products are priced in the consumer-accessible range ($8–$27 USD) and distributed directly through their website with emphasis on accessibility and affordability for family health monitoring.

Lady Technologies is a women's health company developing a proprietary vaginal health platform centered on cervical mucus biomarker analysis. Their flagship product, kegg, is an intravaginal device that measures cervical mucus changes to identify fertile windows, provide pelvic floor training, and deliver actionable health insights. The platform currently focuses on fertility tracking and conception support, with clinical applications extending to non-hormonal contraception, infection detection, and pelvic floor health monitoring. kegg has supported over 50,000 women on their fertility journeys. The company emphasizes a data-driven, personalized approach to women's health by collecting and analyzing the largest known dataset on cervical mucus patterns. Lady Technologies is building a broader vaginal health ecosystem with potential for expanded diagnostic and therapeutic applications beyond fertility.

Applied Science, Inc. develops regulated medical devices and SaaS platforms serving blood collection and chronic care management markets. The company operates two primary business lines: HemoFlow, an automated whole blood collection system for blood banks, and AdaptivMD, a remote patient monitoring and chronic care management platform. HemoFlow provides mixers, software services, and consumables to optimize transfusion medicine workflows, enabling automated paperless collection, error and waste reduction, enhanced phlebotomist productivity, and centralized device management across blood collection facilities. The platform processes approximately 18 million whole blood donations annually, supporting 54 million transfused blood products globally, with 99.74% customer retention over 13 years. AdaptivMD serves community and rural healthcare providers with value-based care solutions, incorporating remote patient monitoring, telehealth, diabetic retinopathy screening, painless blood glucose monitoring, chronic care management, and EHR-integrated workflows to improve health equity for underserved populations. The company has delivered regulated devices and SaaS services for over 15 years to private and public blood banks worldwide. Applied Science emphasizes interoperability, seamless integrations, and automation efficiencies across its platform portfolio. Service capabilities include passionate, experienced, and agile customer support.

Circadia Technologies develops FDA-cleared continuous monitoring and predictive analytics solutions for senior care facilities and payers. The company manufactures the Circadia C200, a contactless radar-based early detection device that monitors heart rate, respiratory rate, bed exits, and patient motion. The C200 integrates with Circadia's proprietary Clinical Intelligence Platform, which uses machine learning and AI to generate real-time alerts and daily risk reports to prevent rehospitalizations and identify fall risks. The platform is marketed as a predictive care solution for skilled nursing facilities (SNFs), assisted living, and other senior care settings. Circadia's technology is Medicare-reimbursable and deployed across major healthcare providers. The company reports monitoring 30,000+ patients daily, with demonstrated outcomes including 30% reduction in rehospitalizations after 12 months and 78% sensitivity for detecting preventable hospitalizations. The C200 is FDA-cleared for its specified vital sign and motion detection capabilities. Circadia serves a network of senior care operators, health systems, and payers with contracted ROI models ($316K yearly per 100-bed SNF for providers; $864K for payers). The company combines hardware (radar-based sensor), software (analytics platform), and clinical services to deliver comprehensive preventive care solutions.

LifeSignals, Inc. is a medical device company specializing in wireless patient monitoring solutions and disposable wearable biosensors for in-hospital, hospital-at-home, and ambulatory care settings. The company develops the UbiqVue™ platform, a cloud-based wireless patient monitoring system that captures continuous vital signs including 2-channel ECG and multiparameter vital signs through single-use, cost-effective biosensors. LifeSignals' patented LSP silicon platform enables disposable sensors designed for mass production, reducing clinical device costs while maintaining clinical-grade accuracy. The UbiqVue Multiparameter system provides near real-time vital sign monitoring for large-scale in-hospital and hospital-at-home delivery; the UbiqVue Holter system delivers cloud-based ECG analysis and reporting for ambulatory cardiac services and mobile cardiac telemetry (MCT). Core technology includes Wi-Fi-centric wireless connectivity with support for multiple radios, HIPAA and GDPR-compliant data transfer, and robust encryption. The company serves healthcare providers, integrated delivery networks, and digital health platforms seeking to untether patients from wired monitoring constraints while enabling data-driven clinical insights. LifeSignals operates manufacturing and integration capabilities with headquarters in Milpitas, CA, and regional offices in India, Europe (Ireland), and Asia-Pacific (Singapore), supporting global deployment of wireless healthcare monitoring infrastructure across population health initiatives.

Neotech Products LLC is a US-based manufacturer of specialized medical consumables and devices for neonatal intensive care units (NICU), pediatric intensive care units (PICU), and home health settings. Founded 30 years ago by Dr. Arnold Heyman, the company designs and manufactures products that serve mothers, babies, children, and clinical caregivers. Product lines include breast-like pacifiers (Neotech Ninni), breastfeeding assistance devices (Neotech Bridge), skin-friendly adhesive solutions, ECG electrodes with hydrocolloid borders (NeoLead), tubing holders (NeoSnug), suctioning accessories, tracheostomy products, respiratory support devices, telemetry accessories, transilluminators, ocular exam products, and phototherapy-related consumables. Neotech also offers mobile device cleaning products and electrode accessories. All products are manufactured in the USA with emphasis on clinical efficacy and patient comfort. The company operates through direct sales and a network of specialty distributors across the US and internationally. Neotech emphasizes collaboration with inventors and product developers, offering free product development assistance. The organization maintains strong focus on home health applications and pediatric clinical environments. Core competencies include neonatal care, pediatric support, breastfeeding facilitation, and infection control through skin-friendly materials.

Smart Caregiver Corporation is an industry leader with over 30 years of expertise in fall prevention and mobility monitoring solutions for high-risk individuals, residents, patients, and elderly populations. The company specializes in affordable, high-quality fall prevention monitors including bed alarms, chair alarms, floor mat sensors, motion detectors, call button systems, and door/window alarms. Their solutions are designed for both home care and facility-based settings, with customizable wireless monitoring systems that enable caregivers to afford the quantity of devices necessary to maintain resident safety and comfort. Products feature wireless alert systems, caregiver pagers, video monitoring capabilities, and centralized monitoring units for larger facilities. Proudly American-owned and operated with a focus on practical, cost-effective safety solutions.

Previon Solutions is a healthcare integration and compliance technology company serving health plans, managed care organizations, and healthcare systems. The company specializes in streamlining administrative and clinical programs through centralized software platforms and fulfillment services. Their core offerings include Previon PrISM, a campaign management platform designed for deploying repeatable program performance in preventative care initiatives; Previon Compliance™, which automates CMS-regulated document fulfillment and communication compliance; and white-labeled self-collection diagnostic kits that enable preventative care through at-home testing. Previon also provides assembly and fulfillment services, outreach solutions, and ongoing client support. The company operates on a consulting and implementation model, beginning with client consultation to understand desired outcomes, followed by comprehensive solution design including materials, branding, and engagement workflows. Staff training and post-implementation support are standard components of their service delivery. Previon serves diverse healthcare segments including virtual care organizations, managed care administrators, and health plans. The company is recognized as a top workplace in Orange County and maintains a client base that values ease of use, compliance automation, and responsive customer service.

UpDoc is a Remote Patient Intervention (RPI) platform combining agentic AI with physician oversight to deliver proactive, evidence-based care for chronic disease management. The platform enables continuous, personalized patient monitoring and intervention between clinical visits through EHR integration and mobile application interfaces. UpDoc's technology operates under physician supervision, automatically monitoring patient metrics (including blood glucose and other chronic disease indicators), driving timely patient engagement, and triggering clinical escalations before deterioration occurs. The platform is designed to increase medication adherence, improve chronic disease outcomes, and expand clinical capacity without proportional increases in labor costs. Clinical validation, published in JAMA Network Open, demonstrated 3x improvement in chronic disease metrics, 65% increase in medication adherence, and 5x expansion of clinical capacity using equivalent staffing. The system targets healthcare organizations, health plans, employers, and healthcare systems seeking to address care gaps between patient visits and reduce both clinical burden and total cost of care. UpDoc is trusted by major medical institutions including Mayo Clinic, UCSF, and University of Minnesota, and has backing from technology and healthcare leaders.

Omada Health is a virtual-first digital therapeutics and care management platform specializing in chronic condition management through evidence-based programs, personalized health coaching, and connected smart devices. Founded in 2011, the company delivers integrated care pathways for prediabetes/weight management, diabetes, hypertension, and musculoskeletal conditions, serving over 1,700 employer and health plan customers covering more than 1 million members. The platform combines behavioral science, one-on-one coaching from certified specialists, continuous monitoring via smart devices (scales, blood pressure monitors, glucose meters, CGM sensors), interactive digital lessons, and peer support communities. Omada integrates data with primary care providers and uses a multidisciplinary clinical and data science approach to drive measurable health outcomes and ROI, with documented savings of $983+ per member in the first year and 88%+ customer satisfaction on cardiometabolic programs.

Siren is a digital health and remote patient monitoring company specializing in smart textile technology for chronic disease management. The company manufactures FDA-registered Siren Socks, wearable temperature-monitoring devices embedded with microsensors that detect early signs of foot inflammation in patients with diabetes and neuropathy. The socks wirelessly transmit data to a monitoring platform where licensed nurses review metrics and alert healthcare providers to potential injuries, enabling early intervention to prevent diabetic foot ulcers. Siren's integrated care management service includes device delivery, continuous nurse-led monitoring, provider alerts, and clinical decision support. The platform operates without requiring smartphone connectivity and features machine-washable, auto-replacing sock technology. The company serves high-risk diabetic populations through partnerships with the US Department of Veterans Affairs and healthcare networks nationwide, focusing on reducing preventable amputations and hospitalizations through proactive foot health surveillance.

Bodyport Inc. is a biomarker-guided digital therapeutics company specializing in remote monitoring solutions for complex chronic conditions, particularly heart failure. The company's FDA-cleared Bodyport Cardiac Scale (Fluiditi™) is a non-invasive, at-home device that measures hemodynamic biomarkers—including heart function and fluid status—through advanced sensors embedded in a bathroom scale. Patients simply step on the device for under 30 seconds, and data transmits via cellular connection to care teams within minutes. The proprietary Congestion Index algorithm combines multiple hemodynamic biomarkers into a composite metric for early detection of worsening heart failure, demonstrating superior performance over traditional weight-based monitoring in clinical validation. Bodyport's integrated care platform combines a clinical portal with a patient app, delivering actionable insights for timely clinician interventions. The system supports RPM billing, integrates via API with leading EHRs, and maintains HIPAA compliance and SOC 2 certification. The company partners with major health systems including Geisinger, Stanford, Duke, and Brigham & Women's Hospital, backed by peer-reviewed clinical evidence published in leading medical journals.

LetsGetChecked Inc. is a direct-to-consumer and B2B healthcare company specializing in at-home health testing, telehealth consultations, and pharmacy services. The company manufactures and distributes at-home sample collection kits analyzed by its own CLIA-certified, CAP-accredited laboratory. Services include comprehensive health screening panels (cancer screening, women's health, men's health, infectious disease, biometric screening, and gap-in-care solutions), board-certified telehealth consultations via secure messaging, and affiliate pharmacy services for medication fulfillment and support. LetsGetChecked operates an integrated platform combining in-house manufacturing, laboratory analysis, clinical consultation, and pharmacy operations. The company serves both individual consumers and institutional clients including employers, health plans, health systems, and large organizations (Amazon, Denver Health, Humana, Berkshire Hathaway, University of Virginia, and others). Over 10 million kits have been used, with service delivery focused on accessibility, privacy, and convenience. The company is part of Fuze Health, a broader healthcare innovation platform. Regulatory compliance includes CLIA laboratory certification and CAP accreditation for clinical testing operations.

Empo Health develops remote monitoring solutions for diabetic foot ulcer (DFU) prevention and management. The company's primary offering is the Empo Footprint imaging scale—a weight-scale form factor device that captures high-resolution images of patients' feet in a home setting—combined with the Empo Remote Health Link patient monitoring service. The system automatically transmits foot images to healthcare providers (podiatrists, primary care physicians, VA facilities) for review and clinical decision-making. The solution targets the 20+ million Americans with diabetic neuropathy who are at high risk for foot ulcers, amputation, and associated mortality. The company positions its offering as reducing the burden of routine foot monitoring on both patients (ease-of-use equivalent to stepping on a scale) and providers (automated image delivery and remote coordination). Clinical evidence cited on the site indicates remote DFU monitoring reduces amputation rates. The company serves podiatrists (DPM), family medicine, nurse practitioners, and health systems. Empo Health operates customer support and holds both product and service components; they maintain a dedicated support portal (support.empohealth.com) and phone/email support infrastructure.

Aulisa Medical is a Palo Alto, CA-based medical device company founded in 2012 that develops FDA-cleared, wireless wearable patient monitoring systems for continuous vital sign tracking in clinical and home environments. The company specializes in cloud-based remote monitoring solutions utilizing artificial intelligence to detect inconsistencies in vital sign data and enable early intervention for potentially adverse events. Products are designed for infants, children, and adults across multiple care settings. The Guardian Angel® product line serves as the primary offering, functioning as both a consumer baby monitor and clinical-grade vital sign monitoring device. Applications include monitoring for sleep safety, chronic respiratory diseases (COPD, sleep apnea), cardiac conditions, post-procedure recovery, and aging-in-place scenarios. The company addresses the need to reduce manual vital sign spot-checking burden for both clinicians and caregivers through automated, continuous monitoring with alert capabilities. Aulisa has achieved FDA clearance for its devices and is backed by Silicon Valley venture capital investors. The company operates both direct-to-consumer and hospital/clinical distribution channels, with products available for in-home use and institutional hospital settings.

Health Solutions Medical Products manufactures SinuPulse®, the original pulsatile nasal irrigation system since 1996. The company specializes in sinus relief devices engineered with patented IntelliPulse™ technology that delivers rhythmic pulsating saline irrigation to clear nasal passages, reduce sinus infections, allergies, and congestion. SinuPulse systems include the Elite (mains-powered, 700ml capacity, dual pulsating spray) and Traveler (cordless, portable) models. Products are supported by dozens of published clinical studies demonstrating efficacy in biofilm removal, ciliary restoration, and symptom relief. SinuPulse devices are FSA/HSA-eligible, carry extended 2-year warranties, and are trusted by professional sports teams, VA Medical Centers, and millions of consumers. The company also manufactures SinuAir® enhanced saline formulations and replacement accessories. Manufacturing and distribution appear US-based with emphasis on American innovation and quality standards.

Vitasora Health Limited is a US-based Connected Care Management Company delivering comprehensive remote patient monitoring and care coordination services to healthcare providers and payers. The company operates a multi-service platform encompassing Chronic Care Management (CCM) for patients with multiple chronic conditions, Principal Care Management (PCM) for single high-risk conditions, Transitional Care Management (TCM) to prevent readmissions, and advanced Remote Patient Monitoring (RPM) with integrated multi-device health metric tracking. The platform features AI-powered decision-making, clinical data analysis, and virtual clinic support delivered by clinically-trained care coordinators. Vitasora currently manages over 6,500 patient programs with reported outcomes including reductions in re-hospitalizations, length of hospital stay, and emergency room visits. The company is listed on the Australian Securities Exchange (ASX) under ticker VHL and operates with strategic partnerships integrated into healthcare provider and payer workflows. Services are marketed toward healthcare providers seeking to extend patient reach, payers managing high-risk populations, and individual patients requiring coordinated chronic disease management and remote health monitoring.

FaceHeart Corporation develops FDA-cleared contactless video-based vital signs measurement software powered by artificial intelligence image recognition technology. The company's flagship product, FaceHeart Vitals™ (registered as FH Vitals SDK), is a Software as Medical Device (SaMD) that measures multiple vital parameters from a 50-second facial scan without requiring wearables or connected devices. The solution has received two FDA 510(k) Class II clearances: one for Heart Rate measurement (k223622) and one for Respiration Rate measurement (k243966). The platform measures heart rate, respiration rate, blood pressure, oxygen saturation, heart rate variability, stress index, and screens for atrial fibrillation. Additional biomarkers in beta development include HbA1c, hemoglobin, and cholesterol. FaceHeart Vitals™ is designed for seamless integration with diverse devices and platforms including mobile phones, laptops, desktops, digital picture frames, smart TVs, smart mirrors, security cameras, and robots, eliminating the need for proprietary hardware. Primary applications span telemedicine and remote healthcare (enabling spot checks, diagnostics, and triage), digital health and wellness applications, and smart device integration for both medical and consumer settings. The technology provides medical-grade accuracy trained on millions of datasets and is compatible with various platforms and operating systems. FaceHeart serves healthcare providers, telemedicine platforms, digital health application developers, and smart device manufacturers seeking to integrate contactless vital sign monitoring. The company has garnered industry recognition, including selection for the Forbes Asia 100 to Watch 2025 list and the MedTech Breakthrough Awards 2025 for Best Biometric Sensor Solution.

Mobi Technologies Inc manufactures consumer-grade personal health monitoring and home care devices distributed through major retail channels including Amazon, Best Buy, Target, and Walmart. The company's product portfolio focuses on homecare diagnostics and connected wellness devices for families, infants, and elderly care. Primary offerings include thermometers (DualScan ear/forehead models with pulse rate monitoring), Wi-Fi-enabled otoscopes for ENT visualization, smart home monitoring cameras (MobiCam line with HD video, two-way audio, night vision, and AI motion detection), medication dispensers with Wi-Fi connectivity, pulse oximeters, emergency alert buttons, and nasal aspirators. Products emphasize ease-of-use, wireless connectivity (Wi-Fi and Bluetooth), mobile app integration, and accessibility for non-clinical users. The company serves 20+ million families and positions products for baby monitoring, elderly care support, and general home health management. Customer service operates Monday–Friday, 8 AM–5 PM PST. Products are retail-focused consumer devices rather than clinical-grade medical equipment; no FDA 510(k), CE mark, or ISO 13485 certifications are mentioned on the site.